Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric stroke: current developments.

Carly Seidman1, Fenella Kirkham, Steven Pavlakis

  • 1Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Current Opinion in Pediatrics
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcranial Doppler Ultrasound Velocity Measurements in Children With Sickle Cell Disease in Kenya.

EJHaem·2026
Same author

Syncope as a Presenting Symptom of MuSK-Associated Myasthenia Gravis: A Case Report.

Journal of child neurology·2025
Same author

Noise Propagation and MP-PCA Image Denoising for High-Resolution Quantitative $R_2^{\rm{*}}$, $T_2^{\rm{*}}$, and Magnetic Susceptibility Mapping (QSM).

IEEE transactions on bio-medical engineering·2025
Same author

Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study.

Health technology assessment (Winchester, England)·2023
Same author

Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) in the 18th Century: Mitochondrial Disorders Are Not of Recent Origin.

Cureus·2022
Same author

Effect of age, cerebral infarcts, vasculopathy and haemoglobin on cognitive function, in Tanzanian children with sickle cell anaemia.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2022
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Pediatric arterial ischemic stroke is rare but serious, especially in sickle cell disease patients. Further research into hemodynamics and autoregulation is crucial for new prevention and treatment strategies.

Area of Science:

  • Neurology
  • Pediatrics
  • Vascular Medicine

Background:

  • Pediatric arterial ischemic stroke (AIS) is uncommon but has significant consequences, including a high recurrence rate.
  • Patients with sickle cell disease and various vasculopathies face a particularly elevated risk.

Purpose of the Study:

  • To review risk factors, vascular physiology, and therapeutic approaches for pediatric AIS.
  • To suggest future research directions and treatment goals for this condition.

Main Methods:

  • Review of existing literature on pediatric AIS.
  • Discussion of identified risk factors, including genetic predispositions.
  • Exploration of vascular physiology, with a focus on sickle cell disease.

Main Results:

Related Experiment Videos

  • Identified risk factors encompass chronic diseases, vasculopathy, acute illness, cardiac conditions, trauma, infection, and prothrombic disorders.
  • Genetic factors are increasingly implicated in AIS, particularly in sickle cell disease, moyamoya, and nitric oxide regulation.
  • Current understanding of pediatric AIS vascular physiology is evolving through animal and human studies. No primary prevention therapy is established, though some therapies are used in sickle cell disease patients. Efficacy of anticoagulants like aspirin, coumadin, and heparin for non-sickle cell AIS is unproven.

Conclusions:

  • Pediatric AIS remains under-recognized and under-studied.
  • Hemodynamic aspects and autoregulation in pediatric AIS, especially in sickle cell disease, require more investigation.
  • Enhanced study of hemodynamics and autoregulation is expected to reveal novel prevention and treatment strategies.